-
1Academic Journal
Source: Высшая школа: научные исследования.
Subject Terms: электроэнцефалографическое исследованне, головноймозг, новый противоэпилептический препарат
-
2Academic Journal
Authors: N. M. Zhuravlev, N. A. Shnayder, R. F. Nasyrova, Н. М. Журавлёв, Н. А. Шнайдер, Р. Ф. Насырова
Source: Pharmacogenetics and Pharmacogenomics; № 1 (2022); 37-52 ; Фармакогенетика и фармакогеномика; № 1 (2022); 37-52 ; 2686-8849 ; 2588-0527
Subject Terms: желудочковая тахиаритмия, antiepileptic drug, cardiac repolarization, QT interval, drug-induced long QT syndrome, sudden death syndrome, ventricular tachyarrhythmia, противоэпилептический препарат, реполяризация желудочков сердца, интервал QT, лекарственно- индуцированный синдром удлинённого интервала QT, синдром внезапной смерти
File Description: application/pdf
Relation: https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/244/236; Карлов В. А. Эпилепсия у детей и взрослых мужчин и женщин. М.: БИНОМ-Пресс, 2019. 896 с. [Karlov VA. Epilepsiya u detej i vzroslyh muzhchin i zhenshchin. Moscow: BINOM-Press, 2019. (In Russ).].; Шнайдер Н. А., Петрова М. М., Петров К. В., Насырова Р. Ф. Фармакологические предикторы нарушения сердечного ритма и проводимости при юношеской миоклонической эпилепсии. Эпилепсия и пароксизмальные состояния. 2021;13(2):168–79. [Shnayder NA, Petrova MM, Petrov KV, Nasyrova RF. Pharmacological predictors of heart rate and conductivity disorders in juvenile myoclonic epilepsy. Epilepsiya i paroksizmalʹnye sostoyania = Epilepsy and Paroxysmal Conditions. 2021;13(2):168–179. (In Russ).]. DOI:10.17749/2077-8333/epi.par.con.2021.051; Бородулина И. В., Рачин А. П. Полинейропатии в практике врача: особенности патогенеза, клиники и современные подходы к лечению болевых и безболевых форм. РМЖ. 2016;25:1705–1710. [Borodulina IV, Rachin AP. Polyneuropathies: pathogenesis, clinical manifestations, and current treatment approaches to painful and painless conditions. RMJ. 2016;25:1705–1710. (In Russ).].; Auerbach DS, Biton Y, Polonsky B, McNitt S, Gross RA, Dirksen RT, Moss AJ. Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications. Transl Res. 2018 Jan;191:81–92.e7. DOI:10.1016/j.trsl.2017.10.002; Talaeı A, Farıdhosseını F, Kazemı H, Fayyazı Bordbar MR, Rezaeı Ardanı A. Topiramatın Şizofreni ve İki Uçlu Duygudurum I Bozukluğu Olan Hastalarda İlaca Bağlı Kilo Alımına Etkileri: Doz Ayarlarının Seçkisiz Klinik Çalışması. [Effect of Topiramate on Drug Associated Weight Gain of Patients with Schizophrenia and Bipolar I Disorders: A Dose Ranging Randomized Trial]. Turk Psikiyatri Derg. 2016 Summer;27(2):0. Turkish. PMID: 27370059.; Демьянов И. А., Сурикова В. В., Мельник Е. Ю. Современные тенденции использования антиконвульсантов в психиатрической практике. Вестник СПбГУ. Медицина. 2017;12(3):235–242. [Current trends in the use of anticonvulsants in psychiatric practice. Vestnik SPbSU. Medicine. 2017;12(3):235–242. (In Russ).]. DOI:10.21638/11701/spbu11.2017.303; Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel). 2021 Jun 11;14(6):560. DOI:10.3390/ph14060560; Федеральный закон от 12.04.2010 № 61-ФЗ (ред. от 11.06.2021) «Об обращении лекарственных средств». [Federal Law No. 61-FZ “Ob obrashchenii lekarstvennyh sredstv” dated 12.04.2010 (as amended on 11.06.2021). (In Russ).].; Приказ Росздравнадзора от 15.02.2017 № 1071 (ред. от 16.07.2020) «Об утверждении Порядка осуществления фармаконадзора». [Order of Roszdravnadzor No. 1071 “Ob utverzhdenii Poryadka osushchestvleniya farmakonadzora” dated 15.02.2017 (as amended on 16.07.2020) (In Russ).].; Бочанова Е. Н., Шнайдер Н. А., Дмитренко Д. В. и др. Опыт регистрации нежелательных побочных реакций на противоэпилептические препараты в клинике Красноярского медицинского университета. Врач. 2016;4:6–8. [Bochanova EN, Shnayder NA, Dmitrenko DV, et al. Experience in recording undesirable side effects from antiepileptic drugs in the Krasnoyarsk medical university clinic. VRACH. 2016;4:6–8. (In Russ).].; Zhuravlev NM, Shnayder NA, Vaiman EE, Abdyrakhmanova AK, Petrova MM, Bochanova EN, Romanova IV, Gavrilyuk OA, Lareva NV, Nasyrova RF. Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk. Personalized Psychiatry and Neurology. 2022;2(1):22–45. DOI:10.52667/2712-9179-2022-2-1-23-45; Приказ Минздрава России от 01.02.2019 № 42 (ред. от 24.08.2020) «Об утверждении ведомственной целевой программы “Развитие фундаментальной, трансляционной и персонализированной медицины”». [Order of the Ministry of Health of Russia No. 42 “On approval of the departmental target program “Development of fundamental, translational and personalized medicine” dated 01.02.2019 (as amended on 24.08.2020). (In Russ).].; Салмина А. Б., Шнайдер Н. А., Михуткина С. В. Современные представления об ионных каналах и каналопатиях (обзор литературы). Сибирское медицинское обозрение.2005;34(1):75–78. [Salmina AB, Shnayder NA, Mikhutkina SV. Sovremennye predstavleniya ob ionnyh kanalah i kanalopatiyah (obzor literatury). Siberian Medical Review. 2005;34(1):75–78. (In Russ).].; Neira V, Enriquez A, Simpson C, Baranchuk A. Update on long QT syndrome. J Cardiovasc Electrophysiol. 2019 Dec;30(12):3068–3078. DOI:10.1111/jce.14227; Nakano Y, Shimizu W. Genetics of long-QT syndrome. J Hum Genet. 2016;61(1):51–55. DOI:10.1038/jhg.2015.74; Alders M, Bikker H, Christiaans I. Long QT Syndrome. 2003 Feb 20 [updated 2018 Feb 8]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301308.; Goldenberg I, Zareba W, Moss AJ. Long QT Syndrome. Curr Probl Cardiol. 2008;33(11):629–694. DOI:10.1016/j.cpcardiol.2008.07.002; Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5(4):868–877. DOI:10.1161/CIRCEP.111.962019. Erratum in: Circ Arrhythm Electrophysiol. 2012 Dec;5(6):e119–20. PMID: 22895603.; Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339(14):960–965. DOI:10.1056/NEJM199810013391404; Nannenberg EA, Sijbrands EJ, Dijksman LM, et al. Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet. 2012;5(2):183–189. DOI:10.1161/CIRCGENETICS.111.961102; Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normalrange corrected QT intervals. J Am Coll Cardiol. 2011;57(1):51–59. DOI:10.1016/j.jacc.2010.07.038; Lankaputhra M, Voskoboinik A. Congenital Long QT Syndrome: A Clinician’s Guide. Internal Medicine Journal. 2021;51(12):1999–2011. DOI:10.1111/imj.15437; Committee For Proprietary Medicinal Products (CPMP) Points to consider: The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: 1997 Dec.; Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54(1):59–68. DOI:10.1016/0002-8703(57)90079-0; Horner JM, Horner MM, Ackerman MJ. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm. 2011;8(11):1698–1704. DOI:10.1016/j.hrthm.2011.05.018; Sy RW, van der Werf C, Chattha IS, et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation. 2011;124(20):2187–2194. DOI:10.1161/CIRCULATIONAHA.111.028258; Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102(23):2849–2855. DOI:10.1161/01.cir.102.23.2849; Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55(18):1955–1961. DOI:10.1016/j.jacc.2009.12.015; Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc. 2002;77(5):413–421. DOI:10.4065/77.5.413; Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004;1(3):276–283. DOI:10.1016/j.hrthm.2004.04.021; Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation. 2006;113(11):1385–1392. DOI:10.1161/CIRCULATIONAHA.105.600445; Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88(2):782–784. DOI:10.1161/01.cir.88.2.782; Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124(20):2181–2184. DOI:10.1161/CIRCULATIONAHA.111.062182; Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932–1963. DOI:10.1016/j.hrthm.2013.05.014; Castiglione A, Odening K. QT-Zeit — Was fange ich eigentlich damit an? [QT Interval and Its Prolongation — What Does It Mean?]. Dtsch Med Wochenschr. 2020 Apr;145(8):536–542. German. DOI:10.1055/a-0969-6312; Эпилепсия и спорт: руководство для врачей / под ред. Н. А. Шнайдер, М. М. Петровой, Р. Ф. Насыровой, О. В. Балберовой. СПб.: ДЕАН, 2022. 248 с. ISBN 978-5-6048707-0-9. [Epilepsy and sport: a guide for physicians. Ed by Shnayder NA, Petrova MM, Nasyrova RF, Balberova OV. Saint-Petersburg: DEAN; 2022. (In Russ).].; Parks KA, Parks CG, Yost JP, et al. Acute blood pressure changes associated with antipsychotic administration to psychiatric inpatients. Prim Care Companion CNS Disord. 2018;20(4):18m02299. DOI:10.4088/PCC.18m02299; Nagy D, DeMeersman R, Gallagher D, et al. QTc interval (cardiac repolarisation): Lengthening after meals. Obes Res. 1997;5:531–537. DOI:10.1002/j.1550-8528.1997.tb00573.x; Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int. 2011;108(41):687–693. DOI:10.3238/arztebl.2011.0687; Brown DW, Giles WH, Greenlund KJ et al. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk. 2001;8(4):227–233. DOI:10.1177/174182670100800407; van Noord C, Eijgelsheim M, Stricker BH. Drug- and non-drugassociated QT interval prolongation. Br J Clin Pharmacol. 2010;70(1):16–23. DOI:10.1111/j.1365-2125.2010.03660.x; Carella MJ, Mantz SL, Rovner DR, et al. Obesity, adiposity, and lengthening of the QT interval: improvement after loss. Int J Obes Relat Metab Disord. 1996;20(10):938–942. PMID: 8910099.; El-Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol.1995:75(14):956–959. DOI:10.1016/s0002-9149(99)80700-0; Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q. 2003;74(3):291–306. DOI:10.1023/a:102412270633745. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:233451.; Shah AA, Aftab A, Coverdale J. QTc prolongation with antipsychotics: is routine ECG monitoring recommended? J Psychiatr Pract. 2014;20(3):196– 206. DOI:10.1097/01.pra.0000450319.21859.6d; Joukamaa M, Heliövaara M, Knekt P, et al. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry. 2006;188(2):122–127. DOI:10.1192/bjp.188.2.122; Escande D. Pharmacogenetics of cardiac K(+) channels. Eur J Pharmacol. 2000;410(2-3):281–287. DOI:10.1016/s0014-2999(00)00821-9; Varkey JN, Frishman WH. Arrhythmogenesis and COVID-19. Cardiol Rev. 2021;29(6):289–291. DOI:10.1097/CRD.0000000000000407; Vincent GM. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu Rev Med. 1998;49:263–274. DOI:10.1146/annurev.med.49.1.263; Khera AV, Mason-Suares Н, Brockman D, et al. Rare Genetic Variants Associated With Sudden Cardiac Death in Adults. J Am Coll Cardiol. 2019;74(21):2623–2634. DOI:10.1016/j.jacc.2019.08.1060; Chen L, Zhang W, Fang C et al. Polymorphism H558R in the human cardiac sodium channel SCN5A gene is associated with atrial fibrillation. J Int Med Res. 2011;39(5):1908–1916. DOI:10.1177/147323001103900535; Spellmann I, Reinhard MA, Veverka D, et al. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors. Eur Arch Psychiatry Clin Neurosci. 2018;268(4):383–390. DOI:10.1007/s00406-018-0880-8; Gouas L, Nicaud V, Berthet M et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet. 2005;13(11):1213–1222. DOI:10.1038/sj.ejhg.5201489; Hobday P, Mahoney D, Urban L, et al. Influence of the common H558R-SCN5A sodium channel polymorphism on the electrocardiographic phenotype in a population-based study. Heart Rhythm. 2005;3:S279–S280. DOI: doi.org/10.1016/j.hrthm.2006.02.837; Lehtinen AB, Daniel KR, Shah SA, et al. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study. Ann Noninvasive Electrocardiol. 2009;14(1):72–79. DOI:10.1111/j.1542-474X.2008.00276.x; Pfeufer A, Sanna S, Arking DE, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet. 2009;41(4):407–414. DOI:10.1038/ng.362; Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000;36(1):1–12. DOI:10.1016/s0735-1097(00)00716-6; Koskela J, Kähönen М, Fan М, et al. Effect of common KCNE1 and SCN5A ion channel gene variants on T-wave alternans, a marker of cardiac repolarization, during clinical exercise stress test: the Finnish Cardiovascular Study. Transl Res. 2008;152(2):49–58. DOI:10.1016/j.trsl.2008.06.003; Barhanin J, Lesage F, Guillemare E, et al. KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current. Nature. 1996;384:78–80. DOI:10.1038/384078a0; Marx SO, Kurokawa J, Reiken S, Motoike H, D’Armiento J, Marks AR, Kass RS. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002 Jan 18;295(5554):496–499. DOI:10.1126/science.1066843; De Villiers CP, van der Merwe L, Crotti L et al. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1. Circ Cardiovasc Genet. 2014;7(5):599–606. DOI:10.1161/CIRCGENETICS.113.000580; Клиническая психофармакогенетика / под ред. Р. Ф. Насыровой, Н. Г. Незнанова.СПб.: ДЕАН, 2020. 408 с. [Clinical psychopharmacogenetics. Ed by Nasyrova RF, Neznanov NG. Saint-Petersburg: DEAN; 2020. (In Russ).].; Balestrini S, Sisodiya Sanjay M. Pharmacogenomics in epilepsy. Neuroscience Letters. 2021;29(6):289–291. DOI:10.1016/j.neulet.2017.01.014; Остроумова О. Д., Голобородова И. В. Влияние отдельных групп лекарственных препаратов на риск удлинения интервала QTс. Consilium Medicum. 2019;21(10):95–106. [Ostroumova OD, Goloborodova IV. The effect of individual groups of drugs on the risk of prolongation of the QTc interval. Consilium Medicum. 2019;21(10):95–106. (In Russ).]. DOI:10.26442/20751753.2019.10.190447; Neznanov NG. A paradigm shift to treat psychoneurological disorders. Personalized Psychiatry and Neurology. 2021;1(1):1–2.; Fanoe S, Kristensen D, Fink-Jensen A, et al. Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J. 2014;35(20):1306–1315. DOI:10.1093/eurheartj/ehu100
-
3Academic Journal
Authors: I. G. Kovalev, E. V. Vasileva, R. O. Bokov, R. M. Salimov, G. I. Kovalev
Source: Фармакокинетика и Фармакодинамика, Vol 0, Iss 2, Pp 25-29 (2017)
Subject Terms: противоэпилептический препарат, леветирацетам, соединение гиж-290, мыши balb/c и c57bl/6, ноотропное действие, тревожность, двигательная активность, закрытый крестообразный лабиринт, anticonvulsant, levetiracetam, 4-phenylpyrrolidone derivative, mice, balb/c, c57bl/6, nootropic action, anxiety, motor activity, closed cross-maze test, Pharmacy and materia medica, RS1-441
File Description: electronic resource
-
4Academic Journal
Authors: E. A. Sоkоvа, V. V. Arkhipov, R. A. Chilova, O. A. Demidova, G. F. Proklova, T. V. Pikuza, Е. А. Сокова, В. В. Архипов, Р. А. Чилова, О. А. Демидова, Г. Ф. Проклова, Т. В. Пикуза
Source: Regulatory Research and Medicine Evaluation; Том 8, № 2 (2018); 72-76 ; Регуляторные исследования и экспертиза лекарственных средств; Том 8, № 2 (2018); 72-76 ; 3034-3453 ; 3034-3062 ; 10.30895/1991-2919-2018-8-2
Subject Terms: терапевтический лекарственный мониторинг, antiepileptic drugs, pharmacokinetics, pharmacogenetics, safety, efficacy, drug transporters, therapeutic drug monitoring, противоэпилептический препарат, фармакокинетика, фармакогенетика, безопасность, эффективность, транспортеры лекарственных средств
File Description: application/pdf
Relation: https://www.vedomostincesmp.ru/jour/article/view/175/157; Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy Outcomes in Women with Epilepsy: a Systematic Review and Metaanalysis of Published Pregnancy Registries and Cohorts. Epilepsy Res. 2008;81(1):1–13.; Chen YH, Chiou HY, Lin HC, Lin HL. Affect of Seizures During Gestation on Pregnancy Outcomes in Women with Epilepsy. Arch Neurol. 2009;66(8):979–84.; Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, et al. The Longer Term Outcome of Children Born to Mothers with Epilepsy. J Neurol Neurosurg Psychiatry 2004;75(11):1575–83.; Chong DJ, Lerman AM. Practice Update: Review of Anticonvulsant Therapy. Curr Neurol Neurosci Rep. 2016;16(4):39.; Hernandez-Diaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, et al. Comparative Safety of Antiepileptic Drugs During Pregnancy. Neurology 2012;78(21):1692–9.; Mawhinney E, Craig J, Morrow J, Russell A, Smithson WH, Parsons L, et al. Levetiracetam in Pregnancy: Results from the UK and Ireland Epilepsy and Pregnancy Registers. Neurology 2013;80(4):400–5.; Шефер К, Шпильманн Х, Феттер К. Лекарственная терапия в период беременности и лактации. М.: Логосфера; 2010.; Isoherranen N, Kenneth E. Drug Metabolism and Transport During Pregnancy: How Does Drug Disposition Change During Pregnancy and What are the Mechanisms That Cause Such Changes? Drug Metab Dispos. 2013;41(2):256–62.; Yerby MS, Friel PN, McCormick K, Koerner M, Van Allen M, Leavitt AM, et al. Pharmacokinetics of Anticonvulsants in Pregnancy: Alterations in Plasma Protein Binding. Epilepsy Res. 1990;5(3):223–8.; McGready R, Stepniewska K, Seaton E, Cho T, Cho D, Ginsberg A, et al. Pregnancy and Use of Oral Contraceptives Reduces the Biotransformation of Proguanil to Cycloguanil. Eur J Clin Pharmacol. 2003;59(7):553–7.; Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R. Lamotrigine Clearance During Pregnancy. Neurology 2002;59(2):251–5.; Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. The Impact of Pregnancy and Childbirth on the Metabolism of Lamotrigine. Neurology 2004;62(2):292–5.; Шнайдер НА, Дмитренко ДВ, Говорина ЮБ, Муравьева АВ, Котловский ЮВ, Бочанова ЕН и др. Влияние полиморфизмов гена CYP2C9 на уровень вальпроевой кислоты в крови у женщин репродуктивного возраста с эпилепсией. Фармакогенетика и фармакогеномика 2015;(2):24–8.; Докукина ТВ, Махров МВ, Гайдукевич ИВ, Гилеп АА, Голубева ТС, Хлебоказов ФП и др. Возможности оптимизации терапии противоэпилептическими средствами с использованием фармакогенетических биомаркеров. Эпилепсия и пароксизмальные состояния 2015;(4):22–8.; Cerveny L, Pavek P, Malakova J, Staud F, Fendrich Z. Lack of Interactions Between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents. Epilepsia 2006;47(3):461–8.; Atkinson D, Brice-Bennet S, D’Souza SW. Antiepileptic Medication During Pregnancy: Does Fetal Genotype Affect Outcome? Pediatr Res 2007;62(2):120–7.; Сокова ЕА. Мониторинг безопасности зарегистрированных лекарственных средств у беременных: фармакогенетические аспекты. Безопасность и риск фармакотерапии 2015;(3):30–5.; Пастернак ЕЮ, Аляутдин РН, Романов БК. Трансформация взглядов на тератогенность противоэпилептической терапии. Безопасность и риск фармакотерапии 2014;(4):12–7.; https://www.vedomostincesmp.ru/jour/article/view/175
-
5